丽珠医药9月10日斥资420.41万元回购10.52万股A股

Core Viewpoint - The company, Lijun Pharmaceutical (01513), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 105,200 A-shares at a total cost of 4.2041 million yuan [1] - The buyback is scheduled to take place on September 10, 2025, reflecting a strategic move to enhance shareholder value [1]